Immutep Ltd
(ASX:IMM)
A$
0.050
+0.0020 (+4.17%)
Market Cap: 70.74 Mil
Enterprise Value: -27.18 Mil
PE Ratio: 9,999.00
PB Ratio: 0.51
GF Score: 0/100 Immutep Ltd Webcast Presentation Transcript
Jun 26, 2024 / 11:00PM GMT
Release Date Price:
A$0.435
(+3.57%)
Operator
(technical difficulty) My name is Paul Xiniya, and I'll be the moderator for today's session. On the call today, we have Executive Director and CEO, Mark Voigt; we have Chief Scientific Officer, Professor Frederick Triebel; Chief Medical Officer, Dr. Florian Vogl; and Senior Vice President Strategic Development, Christian Mueller.
Questions will be taken for the analysts at the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot